NIH’s ORIVA Marks a Shift Toward Human-Centric Research Methodologies
The recent establishment of the NIH Office of Research Integrity, Validation, and Adoption of New…
Newswire
Bristol Myers Squibb and Johnson & Johnson’s Next-Generation Blood Thinner Fails Key Trial
A closely watched next-generation blood thinner being developed by Bristol Myers Squibb and Johnson &…
Magnetically Guided Microrobots Deliver Drugs with Pinpoint Accuracy
Researchers at ETH Zurich have unveiled a groundbreaking magnetically guided microrobotics system designed to navigate…
Lundbeck Initiates Bidding War for Avadel Pharmaceuticals Amidst Competitive Landscape
Avadel Pharmaceuticals has confirmed receipt of an unsolicited acquisition proposal from Lundbeck, marking the beginning…
Merck to Acquire Cidara for $9.2 Billion, Focusing on Influenza Prevention
Merck announced on Friday that it is acquiring Cidara Therapeutics for $9.2 billion, a strategic…
Merck to Acquire Cidara for $9.2 Billion, Expanding Flu Prevention Pipeline
Merck announced on Friday its intention to acquire Cidara Therapeutics, a company focused on developing…
Eli Lilly and Novo Nordisk Disown Mangoceuticals’ GLP-1RA Partnership Claim
Eli Lilly and Novo Nordisk have officially refuted claims made by Mangoceuticals regarding a purported…
Mikael Dolsten Withdraws Board Candidacy at Novo Nordisk Amid Leadership Changes
In a significant development for Novo Nordisk, former Pfizer Chief Scientific Officer Mikael Dolsten has…
Otsuka’s HAE med Dawnzera, Lilly’s oral SERD Inluriyo among drugs scoring EU endorsements
The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has granted endorsements…
Medicxi Secures €500 Million for New Biotech Fund to Transform Patient Care
London-based VC firm Medicxi has successfully closed a new fund totaling €500 million ($581 million),…